[Obstetrical management of Streptococcus agalactiae].
S. agalactiae is the main cause of maternal and neonatal infections. Correct bacteriological explorations of pregnant women and neonates with risk factors may allow early and effective antibiotherapy. The screening of S. agalactiae vaginal carriage at 34-38 weeks of amenorrhea and the administration of penicillin at delivery is considered as the best strategy for preventing S. agalactiae infections for asymptomatic patients.
Quentin
R
R
Département de Gynécologie, Obstétrique et Pathologie de la Reproduction, CHU Bretonneau, 37044 Tours Cedex 1, France.
Morange-Saussier
V
V
Watt
S
S
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D036861:Delivery, Obstetric; D005260:Female; D006801:Humans; D007114:Immunization; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D010406:Penicillins / Q000008:administration & dosage; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D013290:Streptococcal Infections / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission; D013292:Streptococcus agalactiae / Q000145:classification / Q000302:isolation & purification / Q000472:pathogenicity; D014621:Vagina / Q000382:microbiology
D000900:Anti-Bacterial Agents; D010406:Penicillins